Literature DB >> 4506997

Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.

D S Freestone, S Hamilton-Smith, G C Schild, R Buckland, S Chinn, D A Tyrrell.   

Abstract

Forty-nine subjects were vaccinated with either live attenuated, detergent split, or oil adjuvant A2/Hong Kong influenza vaccines, or a saline influenza B vaccine as control. Respiratory symptoms occurred more frequently in subjects who received the live vaccine but in total there was little difference between the symptoms in the four groups. Antibody titres in nasal washings and serum were measured by haemagglutination inhibition, neuraminidase inhibition and virus neutralization tests. The oil adjuvant vaccine stimulated larger antibody responses than the other procedures. Six weeks after vaccination the volunteers were challenged with partially attenuated live A2/Hong Kong influenza virus administered intranasally. The live attenuated and oil adjuvant vaccines provided the best protection against challenge.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4506997      PMCID: PMC2130202          DOI: 10.1017/s0022172400063117

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  6 in total

1.  A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; D Hobson; S E Reed; D A Tyrrell
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

2.  Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines.

Authors:  J C Downie
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

3.  Antibody responses to and efficacy of an inactivated spray vaccine.

Authors:  A S Beare; D Hobson; S E Reed; D A Tyrrell
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Antibody against influenza A2 virus neuraminidase in human sera.

Authors:  G C Schild
Journal:  J Hyg (Lond)       Date:  1969-06

5.  Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.

Authors:  A N Slepushkin; G C Schild; A S Beare; S Chinn; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1971-12

6.  Attenuation of human influenza A viruses.

Authors:  A S Beare; M L Bynoe
Journal:  Br Med J       Date:  1969-10-25
  6 in total
  26 in total

1.  The hamster as an experimental animal for the study of influenza. II. The role of spleen cells in protection.

Authors:  R Jennings; J P Phair; M D Denton; C W Potter
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

2.  Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population.

Authors:  L W Miller; Y Togo; R B Hornick
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

3.  Neutralizing activity in the gastrointestinal contents of piglets vaccinated with an ethylenimine-inactivated porcine enterovirus.

Authors:  D G Hazlett; J B Derbyshire
Journal:  Can J Comp Med       Date:  1977-04

4.  The administration of drugs and vaccines by the intranasal route.

Authors:  D S Freestone; A L Weinberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

5.  Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.

Authors:  K A Callow
Journal:  J Hyg (Lond)       Date:  1985-08

6.  Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

7.  A contribution of cellular immunity to protection against influenza in man.

Authors:  R Jennings; R J Fenton; M G McEntegart; C W Potter
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

8.  Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.

Authors:  W Al-Nakib; J M Best; J E Banatvala
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

9.  Immunity after infections with Myxoviruses.

Authors:  M Majer
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  Transmissibility of influenza viruses in hamsters.

Authors:  M J Ali; C Z Teh; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.